XJPX6951
Market cap1.84bUSD
Dec 24, Last price
5,663.00JPY
1D
1.13%
1Q
4.46%
Jan 2017
455.20%
Name
JEOL Ltd
Chart & Performance
Profile
JEOL Ltd. engages in the research, development, manufacture, and marketing of scientific and metrology instruments, semiconductor and industrial equipment, and medical equipment. It provides transmission electron microscopes; scanning electron microscopes; ion beam application equipment, including specimen preparation equipment and multibeam systems; instruments for microarea and surface analysis, such as electron probe micro analyzers, auger microprobes, and photoelectron spectrometers; magnetic resonance equipment, such as nuclear magnetic resonance and electron spin resonance spectrometers; X-ray fluorescence spectrometers; mass spectrometers; electron beam lithography systems; and clinical chemistry analyzers. The company also offers industrial equipment for thin-film formation and material processing, including thin film formation equipment and material processing equipment. In addition, it engages in the processing, maintenance, and services of related products and parts, as well as procurement and sales of peripherals. The company was formerly known as Japan Electron Optics Laboratory Co., Ltd. and changed its name to JEOL Ltd. in 1961. JEOL Ltd. was incorporated in 1949 and is headquartered in Akishima, Japan.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | 2016‑03 | 2015‑03 | |
Income | ||||||||||
Revenues | 174,336,000 7.16% | 162,689,000 17.54% | 138,408,000 25.33% | |||||||
Cost of revenue | 105,315,000 | 100,378,000 | 91,559,000 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 69,021,000 | 62,311,000 | 46,849,000 | |||||||
NOPBT Margin | 39.59% | 38.30% | 33.85% | |||||||
Operating Taxes | 7,766,000 | 5,884,000 | 4,373,000 | |||||||
Tax Rate | 11.25% | 9.44% | 9.33% | |||||||
NOPAT | 61,255,000 | 56,427,000 | 42,476,000 | |||||||
Net income | 21,704,000 21.73% | 17,830,000 45.22% | 12,278,000 227.85% | |||||||
Dividends | (3,542,000) | (3,386,000) | (1,303,000) | |||||||
Dividend yield | 1.11% | 1.56% | 0.38% | |||||||
Proceeds from repurchase of equity | 22,598,000 | |||||||||
BB yield | -6.61% | |||||||||
Debt | ||||||||||
Debt current | 7,433,000 | 5,370,000 | 5,355,000 | |||||||
Long-term debt | 9,602,000 | 8,112,000 | 12,303,000 | |||||||
Deferred revenue | 3,708,000 | 8,623,000 | 8,645,000 | |||||||
Other long-term liabilities | 11,741,000 | 408,000 | 1,148,000 | |||||||
Net debt | (44,070,000) | (32,952,000) | (38,215,000) | |||||||
Cash flow | ||||||||||
Cash from operating activities | 15,301,000 | 3,351,000 | 22,603,000 | |||||||
CAPEX | (3,243,000) | (6,389,000) | (1,515,000) | |||||||
Cash from investing activities | (18,028,000) | (5,734,000) | (648,000) | |||||||
Cash from financing activities | (798,000) | (8,732,000) | 5,517,000 | |||||||
FCF | 40,240,000 | 38,076,000 | 53,581,000 | |||||||
Balance | ||||||||||
Cash | 31,504,000 | 34,254,000 | 44,226,000 | |||||||
Long term investments | 29,601,000 | 12,180,000 | 11,647,000 | |||||||
Excess cash | 52,388,200 | 38,299,550 | 48,952,600 | |||||||
Stockholders' equity | 105,089,000 | 81,525,000 | 65,654,000 | |||||||
Invested Capital | 96,938,800 | 80,254,450 | 59,515,400 | |||||||
ROIC | 69.14% | 80.74% | 65.23% | |||||||
ROCE | 46.15% | 52.41% | 43.06% | |||||||
EV | ||||||||||
Common stock shares outstanding | 51,079 | 51,042 | 49,756 | |||||||
Price | 6,258.00 47.42% | 4,245.00 -38.21% | 6,870.00 56.49% | |||||||
Market cap | 319,652,382 47.53% | 216,673,290 -36.61% | 341,823,720 61.15% | |||||||
EV | 275,582,382 | 183,721,290 | 303,608,720 | |||||||
EBITDA | 73,768,000 | 67,233,000 | 51,183,000 | |||||||
EV/EBITDA | 3.74 | 2.73 | 5.93 | |||||||
Interest | 88,000 | 73,000 | 129,000 | |||||||
Interest/NOPBT | 0.13% | 0.12% | 0.28% |